Chemoinformatics Market Size is Poised to be USD 19.12 Billion by 2035 Due to the Integration of AI and ML Globally | SNS Insider
U.S. Chemoinformatics Market was valued at USD 1.87 billion in 2025 and is expected to reach USD 7.91 billion by 2035 due to the presence of the largest pharmaceutical R&D ecosystem globally
Austin, April 02, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Chemoinformatics Market size was valued at USD 4.51 billion in 2025 and is expected to reach USD 19.12 billion by 2035, growing at a CAGR of 15.55% over 2026-2035.
The pharmaceutical industry’s use of artificial intelligence, machine learning, and sophisticated molecular modeling technologies in drug development and chemical research is driving the rapid growth of the global chemoinformatics market.
Request Instant Access to the Chemoinformatics Market Forecast @ https://www.snsinsider.com/sample-request/6931
Chemoinformatics Market Size and Forecast:
- Market Size in 2025: USD 4.51 billion
- Market Size by 2035: USD 19.12 billion
- CAGR: 15.55% from 2026 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
The U.S. Chemoinformatics Market was valued at USD 1.87 billion in 2025 and is expected to reach USD 7.91 billion by 2035, growing at a CAGR of 15.48% from 2026-2035.
With the world’s largest pharmaceutical R&D ecosystem, top computational chemistry software providers, and substantial government funding for AI-based drug discovery projects from the NIH, DARPA, and NSF, the United States holds the largest market share in the global chemoinformatics market.
Accelerating AI Integration in Drug Discovery Pipelines to Boost Market Expansion Globally
The most revolutionary and significant growth driver for the chemoinformatics industry is the incorporation of artificial intelligence, machine learning, and deep learning algorithms into pharmaceutical drug discovery. Pharmaceutical scientists can now screen virtual compound libraries of more than one billion molecules in silico, predict ADMET (absorption, distribution, metabolism, excretion, toxicity) properties more accurately, and rank lead candidates for experimental synthesis with much lower attrition rates thanks to AI-powered chemoinformatics tools. Large pharmaceutical companies and up-and-coming biotech companies are rapidly adopting generative molecular design platforms, scaffold optimization tools based on reinforcement learning, and large-scale molecular property prediction models for commercial use. This is directly driving software subscription, licensing, and professional service revenues in the global chemoinformatics market.
Chemoinformatics Market Segmentation Analysis:
By Application
Due to the pharmaceutical industry’s extensive use of drug discovery techniques, such as virtual screening, molecular docking, de novo drug design, and QSAR-based lead optimization, the drug discovery segment accounted for the biggest revenue share in 2025, at over 47.68%. The drug validation segment is expected to exhibit the maximum CAGR of around 17.84% in the forecast period of 2026-2035, owing to the increased regulatory acceptance of in silico validation data in IND and NDA submissions and the increased adoption of physiologically based pharmacokinetic modeling in drug approval processes globally.
Chemoinformatics Market Regional Insights:
With the largest revenue share of around 41.47% in 2025, North America dominated the market. The most cutting-edge pharmaceutical R&D facilities globally, is located in the area. The NIH and DARPA have the biggest R&D funding for AI-based drug discovery programs in the region, which is also home to the most well-known cheminformatics software businesses.
Asia Pacific is the fastest-growing regional segment of the chemoinformatics market with an 18.27% CAGR due to the rapid growth of the local pharmaceutical and biotech industry in China, India, Japan, and South Korea.
In 2025, Europe accounted for about 28.16% of the world’s chemoinformatics market revenue thanks to a robust computational chemistry research tradition rooted in institutions in Germany, the U.K., Switzerland, and the Netherlands, as well as a thriving pharmaceutical and specialty chemicals sector.
For a Custom Market Outlook Discussion with Our Analysts, Connect Now @ https://www.snsinsider.com/request-analyst/6931
Major Players Analysis Listed in the Chemoinformatics Market Report:
- Schrödinger, Inc.
- Dassault Systèmes (BIOVIA)
- Certara, Inc.
- PerkinElmer, Inc.
- Simulations Plus, Inc.
- OpenEye Scientific Software
- Chemical Computing Group (CCG)
- ChemAxon Kft.
- Cresset Group
- BioSolveIT GmbH
- Molecular Discovery Ltd.
- Optibrium Ltd.
- Dotmatics (Insightful Science)
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Insilico Medicine
- Recursion Pharmaceuticals, Inc.
- Intellegens Ltd.
- Exscientia plc
- Enamine Ltd.
Chemoinformatics Market Recent Developments:
- In October 2024, Schrödinger launched its next-generation molecular dynamics platform with integrated machine learning potentials, enabling pharmaceutical partners to achieve up to 50-fold acceleration in protein-ligand binding free energy calculations, significantly enhancing the throughput and commercial value of its drug discovery collaboration programs.
- In March 2024, Dassault Systèmes BIOVIA released an enhanced version of its Pipeline Pilot cheminformatics workflow platform featuring native integration with cloud-based AI model repositories, enabling pharmaceutical scientists to deploy pre-trained molecular property prediction models directly within existing drug discovery data pipelines without requiring additional programming expertise.
Purchase Single User PDF of Chemoinformatics Market Intelligence Report @ https://www.snsinsider.com/checkout/6931
Exclusive Sections of the Report (The USPs):
- AI & MACHINE LEARNING ADOPTION METRICS – helps you understand the penetration of AI-driven virtual screening, QSAR model accuracy, reduction in drug discovery timelines, and adoption of generative molecular design tools across enterprises.
- CHEMICAL DATABASE SCALE & DATA UTILIZATION METRICS – helps you evaluate the growth of virtual compound libraries, usage trends of open vs. proprietary databases, and integration of chemical data platforms with drug discovery systems.
- REGULATORY ACCEPTANCE & IN-SILICO VALIDATION METRICS – helps you track the acceptance of in-silico ADMET data by regulatory bodies, PBPK model approvals, and compliance with global frameworks such as REACH and ICH standards.
- INVESTMENT & FUNDING ACTIVITY METRICS – helps you analyze venture capital inflows, private equity investments, and overall funding trends supporting innovation in AI-driven chemoinformatics solutions.
- PARTNERSHIP & COMMERCIALIZATION METRICS – helps you assess collaboration trends between pharmaceutical companies and technology vendors, along with technology transfer rates from academia to industry.
- CLOUD & SAAS ADOPTION METRICS – helps you identify the shift toward cloud-based chemoinformatics platforms and compare SaaS revenue growth against traditional on-premise licensing models.
Chemoinformatics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 4.51 Billion |
| Market Size by 2035 | USD 19.12 Billion |
| CAGR | CAGR of 15.55% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Application (Chemical Analysis, Drug Discovery, Drug Validation, and Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Demand for Industry Analysis: Our Comprehensive Report Chemoinformatics Market @ https://www.snsinsider.com/reports/chemoinformatics-market-6931
Other Related Report:
Drug Discovery Informatics Market
Artificial Intelligence in Drug Discovery Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.
